EP1032694A2 - Sequences d'acides nucleiques d'hydroperoxyde lyase d'acides gras - Google Patents

Sequences d'acides nucleiques d'hydroperoxyde lyase d'acides gras

Info

Publication number
EP1032694A2
EP1032694A2 EP99930829A EP99930829A EP1032694A2 EP 1032694 A2 EP1032694 A2 EP 1032694A2 EP 99930829 A EP99930829 A EP 99930829A EP 99930829 A EP99930829 A EP 99930829A EP 1032694 A2 EP1032694 A2 EP 1032694A2
Authority
EP
European Patent Office
Prior art keywords
sequence
plant
hpo
lyase
hpo lyase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99930829A
Other languages
German (de)
English (en)
Inventor
Kenji Matsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Calgene LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calgene LLC filed Critical Calgene LLC
Publication of EP1032694A2 publication Critical patent/EP1032694A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Definitions

  • This invention relates to the application of genetic engineering techniques to plants. More specifically, the invention relates to plant hydroperoxide lyase sequences and methods for the use of such sequences.
  • Degradation of polyunsaturated fatty acids starts by the oxygenation atcis-cis double bonds of polyunsaturated fatty acids. This reaction is catalyzed by lipoxygenase (EC 1.13.11.12) enzymes which are present in plants, animals and microorganisms .
  • the oxygenated products called fatty acid hydroperoxides, are precursors for many important hormones (e.g. lipoxins, jasmonic acid, traumatic acid) and flavor/fragrance molecules (e.g. cis-3-hexenol, l-octen-3-ol) in plants.
  • Compounds, such as jasmonic acid are produced from hydroperoxides, such as 13- hydroperoxylinolenic acid, via an allene oxide synthase (referred to as AOS) and an allene oxide cyclase (referred to as ACS)-dependent pathway. Jasmonic acid is involved in stress and disease resistance signaling responses via the octadecanoid pathway. 13- hydroperoxylinolenic can also be catabolized by peroxygenases to form cutin monomers. Alternatively, 13 -hydroperoxylinolenic can be catabolyzed by hydroperoxide lyase eventually forming volatile aldehydes and traumatic acid.
  • Fatty acid hydroperoxide lyase catalyzes the cleavage of carbon-carbon bonds in polyunsaturated fatty acid hyroperoxides to produce short-chain aldehydes and ⁇ - oxo-acids (Vick, et al. (1976) Plant Physiol. 57:780-788).
  • the products of lysis of fatty acid hydroperoxides, such as short-chain volatile aldehydes are common in plant species.
  • the short-chain volatile aldehydes contribute to the "green notes” in a wide variety of plant leaves, vegetables and fruits. "Green notes” are volatile molecules that contribute to the organoleptic qualities of flavor and fragrance of edible plant tissues.
  • hydroperoxide also referred to as HPO lyase or HPOL
  • HPO lyase HPOL
  • HPOL hydroperoxide
  • the present invention is directed to hydroperoxide lyase (also referred to herein as HPO lyase and HPOL), and in particular to HPO lyase polynucleotides.
  • HPO lyase and HPOL hydroperoxide lyase
  • the polynucleotides of the present invention include those derived from plant sources.
  • polynucloetides are provided which encode HPO lyase polypeptides.
  • polynucleotides are provided which encode 13-HPO lyase polypeptides, and polynucleotides are provided encoding 9-HPO lyase polypeptides.
  • One aspect of the present invention relates to oligonucleotides which include partial or complete HPO lyase encoding sequences.
  • constructs which can be used for transcription or transcription and translation (expression) of HPO lyase.
  • constructs are provided which are capable of transcription or transcription and translation in host cells.
  • Particularly preferred constructs are those capable of transcription or transcription and translation in plant cells.
  • HPO lyase in another aspect of the present invention, methods are provided for production of HPO lyase in a host cell or progeny thereof.
  • host cells are transformed or transfected with a DNA construct which can be used for transcription or transcription and translation of HPO lyase.
  • the recombinant cells which contain HPO lyase are also part of the present invention.
  • Particularly preferred host cells include yeast, bacterial, insect, and plant cells.
  • the present invention relates to methods of using polynucleotide and polypeptide sequences to modify the volatile content of host cells.
  • Preferred host cells of the present invention include bacterial, yeast, insect and plant host cells. Host cells having such a modified volatile content are also contemplated herein.
  • modified host cells and oils obtained by the expression or suppression of the HPO lyase proteins are also considered part of the invention.
  • Figure 1 shows the complete nucleotide sequence of the Arabidopsis HPO lyase.
  • Figure 2 shows a comparison of the amino acid sequences of the bell pepper HPO lyase and the Arabidopsis HPO lyase-like sequence.
  • Figure 3 shows a comparison of the amino acid sequences of i e Arabidopsis allene oxide synthase and the Arabidopsis HPO lyase-like sequence.
  • Figure 4 shows the complete nucleotide sequence of the tomato HPO lyase.
  • Figure 5 shows the complete nucleotide sequence of the cucumber allene oxide synthase.
  • Figure 6 shows the complete nucleotide sequence of the cucumber 9-Hydroperoxide Lyase.
  • Figure 7 shows the amino acid sequence alignment between the bell pepper, banana, and Arabidopsis HPO lyase, with the highly conserved peptide sequences highlighted.
  • Figure 8 Provides the percent similarity in the upper right corner and the percent divergence in the lower right corner for the nucleotide sequences ( Figure 8A) and amino acid sequences (Figure 8B) of the bell pepper HPOL (CaHPOL), tomato fruit HPOL (LeHPOL), cucumber hypocotyl HPOL (CsC17HPOL,pseudogene), Arabidopsis inflorecence HPOL (AtHPOL), banana leaf HPOL (MsHPOL), cucumber hypocotyl 9-HPOL (Csl5HPOL), Guayule AOS (GuAOS), flaxseed AOS (LiAOS), and the Arabidopsis AOS (AtAOS).
  • Figure 9 shows the gas chromatography (GC) analysis of the cucumber 9-HPO lyase using linoleic acid 13 -hydroperoxide ( Figure 9A) and linoleic acid 9- hydroperoxide (figure 9B) substrates.
  • GC gas chromatography
  • Figure 10 provides the results of the spectrophotometric assay of the cucumber 9- HPO lyase expressed fromE. coli using linoleic acid 13 -hydroperoxide and linoleic acid 9- hydroperoxide substrates.
  • the present invention relates to hydroperoxide lyase (also referred to herein as HPO lyase and HPOL), particularly the isolated HPO lyase nucleic acid sequences encoding the HPO lyase protein from plant sources.
  • a hydroperoxide lyase of this invention includes any nucleic acid sequence encoding amino acids from a host cell source, such as a polypeptide, obtainable from a cell source, which demonstrates the ability to form short-chain aldehydes and oxo-acids from fatty acid hydroperoxides under plant enzyme reactive conditions.
  • enzyme reactive conditions are meant that any necessary conditions are available in an environment (i.e., such factors as temperature, pH, lack of inhibiting substances) which will permit the enzyme to function.
  • enzyme reactive conditions is meant that any necessary conditions are available in an environment (i.e., such factors as temperature, pH, lack of inhibiting substances) which will permit the enzyme to function.
  • HPO lyase encoding sequence refers to any polynucleotide sequence which encodes a hydroperoxide lyase polypeptide which is capable of producing short-chain aldehydes and oxo-acids from fatty acid hydroperoxides.
  • HPO lyase encoding sequence can encode polypeptides having preferential activity towards particular fatty acid hydroperoxides.
  • Particular fatty acid hydroperoxides include, but are not limited to fatty acid 13-hydroperoxide, and fatty acid 9-hydroperoxide.
  • 13-hydroperoxide lyase refers to any enzyme which forms short chain aldehydes and oxo-acids from fatty acid 13- hydroperoxides.
  • short chain aldehydes include, but are not limited to cis 3- Hexenal and examples of oxo-acids include, but are not limited to 12-oxo-(9Z)dodecenoic acid.
  • fatty acid 13-hydroperoxide include, but is not limited to Linolenic acid 13-hydroperoxide.
  • 9-hydroperoxide lyase refers to any enzyme which forms short chain aldehydes and oxo-acids from fatty acid 9- hydroperoxides.
  • short chain aldehydes include, but are not limited to (3Z,6Z)- nonadienal and examples of oxo-acids include, but are not limited to 9-oxo-nonanoic acid.
  • fatty acid 9-hydroperoxide include, but is not limited to Linolenic acid 9- hydroperoxide or 9-hydroperoxy-(10E, 12Z, 15Z)-octadecadienoic acid.
  • a first aspect of the present invention relates to isolated HPO lyase polynucleotides.
  • the polynucleotide sequences of the present invention include isolated polynucleotides that encode the polypeptides of the invention having a deduced amino acid sequence selected from the group of sequences set forth in the Sequence Listing and to other polynucleotide sequences closely related to such sequences and variants thereof.
  • the invention provides a polynucleotide sequence identical over its entire length to each coding sequence as set forth in the Sequence Listing.
  • the invention also provides the coding sequence for the mature polypeptide or a fragment thereof, as well as the coding sequence for the mature polypeptide or a fragment thereof in a reading frame with other coding sequences, such as those encoding a leader or secretory sequence, a pre-, pro-, or prepro- protein sequence.
  • the polynucleotide can also include non-coding sequences, including for example, but not limited to, non-coding 5' and 3' sequences, such as the transcribed, untranslated sequences, termination signals, ribosome binding sites, sequences that stabilize mRNA, introns, polyadenylation signals, and additional coding sequence that encodes additional amino acids.
  • non-coding sequences including for example, but not limited to, non-coding 5' and 3' sequences, such as the transcribed, untranslated sequences, termination signals, ribosome binding sites, sequences that stabilize mRNA, introns, polyadenylation signals, and additional coding sequence that encodes additional amino acids.
  • a marker sequence can be included to facilitate the purification of the fused polypeptide.
  • Polynucleotides of the present invention also include polynucleotides comprising a structural gene and the naturally associated sequences that control gene expression.
  • the invention also includes polynucleotides of the formula: X-(R,) n -(R 2 )-(R 3 ) complicat-Y wherein, at the 5' end, X is hydrogen, and at the 3' end, Y is hydrogen or a metal, R
  • R 2 is oriented so that its 5' end residue is at the left, bound to R ⁇ , and its 3' end residue is at the right, bound to R 3 .
  • Any stretch of nucleic acid residues denoted by either R group, where R is greater than 1, may be either a heteropolymer or a homopolymer, preferably a heteropolymer.
  • the invention also relates to variants of the polynucleotides described herein that encode for variants of the polypeptides of the invention. Variants that are fragments of the polynucleotides of the invention can be used to synthesize full-length polynucleotides of the invention.
  • Preferred embodiments are polynucleotides encoding polypeptide variants wherein 5 to 10, 1 to 5, 1 to 3, 2, 1 or no amino acid residues of a polypeptide sequence of the invention are substituted, added or deleted, in any combination. Particularly preferred are substitutions, additions, and deletions that are silent such that they do not alter the properties or activities of the polynucleotide or polypeptide.
  • polynucleotide encoding a polypeptide of the invention and polynucleotides that are complementary to such polynucleotides. More preferable are polynucleotides that comprise a region that is at least 80% identical over its entire length to a polynucleotide encoding a polypeptide of the invention and polynucleotides that are complementary thereto. In this regard, polynucleotides at least 90% identical over their entire length are particularly preferred, those at least 95% identical are especially preferred.
  • Preferred embodiments are polynucleotides that encode polypeptides that retain substantially the same biological function or activity as the mature polypeptides encoded by the polynucleotides set forth in the Sequence Listing.
  • the invention further relates to polynucleotides that hybridize to the above-described sequences.
  • the invention relates to polynucleotides that hybridize under stringent conditions to the above-described polynucleotides.
  • stringent conditions and “stringent hybridization conditions” mean that hybridization will generally occur if there is at least 95% and preferably at least 97% identity between the sequences.
  • An example of stringent hybridization conditions is overnight incubation at 42°C in a solution comprising 50% formamide, 5x SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5x Denhardt's solution, 10% dextran sulfate, and 20 micrograms/milliliter denatured, sheared salmon sperm DNA, followed by washing the hybridization support in 0.1 x SSC at approximately 65°C.
  • the invention also provides a polynucleotide consisting essentially of a polynucleotide sequence obtainable by screening an appropriate library containing the complete gene for a polynucleotide sequence set for in the Sequence Listing under stringent hybridization conditions with a probe having the sequence of said polynucleotide sequence or a fragment thereof; and isolating said polynucleotide sequence. Fragments useful for obtaining such a polynucleotide include, for example, probes and primers as described herein.
  • polynucleotides of the invention can be used as a hybridization probe for RNA, cDNA, or genomic DNA to isolate full length cDNAs or genomic clones encoding a polypeptide and to isolate cDNA or genomic clones of other genes that have a high sequence similarity to a polynucleotide set forth in the Sequence Listing.
  • probes will generally comprise at least
  • each gene that comprises or is comprised by a polynucleotide sequence set forth in the Sequence Listing may be isolated by screening using a DNA sequence provided in the Sequence Listing to synthesize an oligonucleotide probe.
  • a labeled oligonucleotide having a sequence complementary to that of a gene of the invention is then used to screen a library of cDNA, genomic DNA or mRNA to identify members of the library which hybridize to the probe.
  • synthetic oligonucleotides are prepared which correspond to the HPO lyase EST sequences.
  • oligonucleotides are used as primers in polymerase chain reaction (PCR) techniques to obtain 5' and 3' terminal sequence of HPO lyase genes.
  • PCR polymerase chain reaction
  • probes may be used directly to screen gene libraries for HPO lyase gene sequences.
  • screening of cDNA libraries inphage vectors is useful in such methods due to lower levels of background hybridization.
  • a HPO lyase sequence obtainable from the use of nucleic acid probes will show 60-70% sequence identity between the target HPO lyase sequence and the encoding sequence used as a probe.
  • lengthy sequences with as little as 50-60% sequence identity may also be obtained.
  • the nucleic acid probes may be a lengthy fragment of the nucleic acid sequence, or may also be a shorter, oligonucleotide probe. When longer nucleic acid fragments are employed as probes (greater than about 100 bp), one may screen at lower stringencies in order to obtain sequences from the target sample which have 20-50% deviation (i.e., 50-80% sequence homology) from the sequences used as probe.
  • Oligonucleotide probes can be considerably shorter than the entire nucleic acid sequence encoding an HPO lyase enzyme, but should be at least about 10, preferably at least about 15, and more preferably at least about 20 nucleotides. A higher degree of sequence identity is desired when shorter regions are used as opposed to longer regions. It may thus be desirable to identify regions of highly conserved amino acid sequence to design oligonucleotide probes for detecting and recovering other related HPO lyase genes. Shorter probes are often particularly useful for polymerase chain reactions (PCR), especially when highly conserved sequences can be identified. ⁇ See, Gould, et al, PNAS USA (1989) 56:1934-1938.).
  • PCR polymerase chain reactions
  • polypeptides include isolated polypeptides set forth in the Sequence Listing, as well as polypeptides and fragments thereof, particularly those polypeptides which exhibit HPO lyase activity and also those polypeptides which have at least 50%, 60% or 70% identity, preferably at least 80% identity, more preferably at least 90% identity, and most preferably at least 95% identity to a polypeptide sequence selected from the group of sequences set forth in the Sequence Listing, and also include portions of such polypeptides, wherein such portion of the polypeptide preferably includes at least 30 amino acids and more preferably includes at least 50 amino acids.
  • Identity is a relationship between two or more polypeptide sequences or two or more polynucleotide sequences, as determined by comparing the sequences.
  • identity also means the degree of sequence relatedness between polypeptide or polynucleotide sequences, as determined by the match between strings of such sequences.
  • Identity can be readily calculated by known methods including, but not limited to, those described in Computational Molecular Biology, Lesk, A.M., ed., Oxford University Press, New York (1988); Biocomputing: Informatics and Genome Projects, Smith, D.W., ed., Academic Press, New York, 1993; Computer Analysis of Sequence Data, Part i, Griffin, A.M.
  • Computer programs which can be used to determine identity between two sequences include, but are not limited to, GCG (Devereux, J., et al., Nucleic Acids Research 12(1):387 (1984); suite of five BLAST programs, three designed for nucleotide sequences queries (BLASTN, BLASTX, and TBLASTX) and two designed for protein sequence queries (BLASTP and TBLASTN) (Coulson, Trends in Biotechnology, 12: 76-80 (1994); Birren, et al, Genome Analysis, 1: 543-559 (1997)).
  • the BLAST X program is publicly available from NCBI and other sources ⁇ BLAST Manual Altschul, S., et al, NCBI NLM NIH, Bethesda, MD 20894; Altschul, S., et al, J. Mol. BioL, 215:403-410 (1990)).
  • the well known Smith Waterman algorithm can also be used to determine identity.
  • Parameters for polypeptide sequence comparison typically include the following: Algorithm: Needleman and Wunsch, J. Mol. BioL 48:443-453 (1970) Comparison matrix: BLOSSUM62 from Hentikoff and Hentikoff, Proc. Natl. Acad.
  • the invention also includes polypeptides of the formula: X-(R,) n -(R 2 )-(R 3 )n-Y wherein, at the amino terminus, X is hydrogen, and at the carboxyl terminus, Y is hydrogen or a metal, Ri and R 3 are any amino acid residue, n is an integer between 1 and 1000, and R 2 is an amino acid sequence of the invention, particularly an amino acid sequence selected from the group set forth in the Sequence Listing.
  • R 2 is oriented so that its amino terminal residue is at the left, bound to Ri, and its carboxy terminal residue is at the right, bound to R 3 .
  • Any stretch of amino acid residues denoted by either R group, where R is greater than 1 may be either a heteropolymer or a homopolymer, preferably a heteropolymer.
  • polypeptides of the present invention can be mature protein or can be part of a fusion protein.
  • a fragment is a variant polypeptide which has an amino acid sequence that is entirely the same as part but not all of the amino acid sequence of the previously described polypeptides.
  • the fragments can be "free-standing" or comprised within a larger polypeptide of which the fragment forms a part or a region, most preferably as a single continuous region.
  • Preferred fragments are biologically active fragments which are those fragments that mediate activities of the polypeptides of the invention, including those with similar activity or improved activity or with a decreased activity. Also included are those fragments that antigenic or immunogenic in an animal, particularly a human.
  • Variants of the polypeptide also include polypeptides that vary from the sequences set forth in the Sequence Listing by conservative amino acid substitutions, substitution of a residue by another with like characteristics. In general, such substitutions are among Ala, Val, Leu and He; between Ser and Thr; between Asp and Glu; between Asn and Gin; between Lys and Arg; or between Phe and Tyr. Particularly preferred are variants in which 5 to 10; 1 to 5; 1 to 3 or one amino acid(s) are substituted, deleted, or added, in any combination.
  • Variants that are fragments of the polypeptides of the invention can be used to produce the corresponding full length polypeptide by peptide synthesis. Therefore, these variants can be used as intermediates for producing the full-length polypeptides of the invention.
  • polynucleotides and polypeptides of the invention can be used, for example, in the transformation of host cells, such as plant host cells, as further discussed herein.
  • the invention also provides polynucleotides that encode a polypeptide that is a mature protein plus additional amino or carboxyl-terminal amino acids, or amino acids within the mature polypeptide (for example, when the mature form of the protein has more than one polypeptide chain).
  • Such sequences can, for example, play a role in the processing of a protein from a precursor to a mature form, allow protein transport, shorten or lengthen protein half-life, or facilitate manipulation of the protein in assays or production. It is contemplated that cellular enzymes can be used to remove any additional amino acids from the mature protein.
  • a precursor protein, having the mature form of the polypeptide fused to one or more prosequences may be an inactive form of the polypeptide.
  • the inactive precursors generally are activated when the prosequences are removed. Some or all of the prosequences may be removed prior to activation.
  • Such precursor protein are generally called proproteins.
  • Genbank a nucleic acid sequence from Arabidopsis is identified from Genbank which is highly homologous to a bell pepper HPO lyase. The Arabidopsis sequence had been previously reported to encode allene oxide synthase. Nucleic acid sequence comparisons between the bell pepper HPO lyase, an Arabidopsis allene oxide synthase (Laudert, et al. (1996) Plant Mol Biol 31(2)323-335), and the Arabidopsis sequence from Genbank indicates that the Arabidopsis sequence is more similar to the bell pepper HPO lyase than to the allene oxide synthase.
  • nucleic acid sequence from cucumber ⁇ Cucumis sativus is identified from cDNA libraries made from total RNA isolated from cucumber hypocotyls.
  • a full length coding sequence is obtained, and the product encoded by the full length sequence demonstrates activity towards the substrate linolenic acid 9- hydroperoxide to produce (3Z, 6Z)-nonadienal and 9-oxo-nonanoic acid.
  • nucleotide sequences in recombinant DNA constructs to direct the transcription or transcription and translation (expression) of the HPO lyase sequences of the present invention in a host cell.
  • polynucleotide sequences of the present invention in recombinant DNA constructs to direct the transcription or transcription and translation (expression) of the HPO lyase sequences of the present invention in a host plant cell.
  • the expression constructs generally comprise a promoter functional in a host cell operably linked to a nucleic acid sequence encoding an HPO lyase of the present invention and a transcriptional termination region functional in a host plant cell.
  • promoters also referred to as transcriptional initiation regions
  • chloroplast and plastid specific promoters which are functional in plant cells, and have been described in the literature.
  • chloroplast or plastid functional promoters and chloroplast or plastid operable promoters are also envisioned.
  • promoters functional in plant cells are constitutive promoters such as the CaMV35S or FMV35S promoters that yield high levels of expression in most plant organs.
  • Enhanced or duplicated versions of the CaMV35S and FMV35S promoters are useful in the practice of this invention (Odell, et al. (1985) Nature 313:810-812; Rogers, U.S. Patent Number 5,378, 619).
  • nucleic acid sequences of the present invention from transcription initiation regions which are preferentially expressed in a plant seed tissue.
  • seed preferential transcription initiation sequences include those sequences derived from sequences encoding plant storage protein genes or from genes involved in fatty acid biosynthesis in oilseeds.
  • promoters include the 5' regulatory regions from such genes as napin (Kridl et al., Seed Sci. Res. 7:209:219 (1991)), phaseolin, zein, soybean trypsin inhibitor, ACP, stearoyl-ACP desaturase, soybean ' subunit of ⁇ -conglycinin (soy 7s, (Chen et al, Proc. Natl. Acad.
  • CTP chloroplast transit peptides
  • PTP plastid transit peptides
  • the expression construct will additionally contain a gene encoding a transit peptide to direct the gene of interest to the plastid.
  • the chloroplast transit peptides may be derived from the gene of interest, or may be derived from a heterologous sequence having a CTP.
  • Such transit peptides are known in the art. See, for example, Von Heijne et al. (1991) Plant Mol. Biol Rep. 9: 104-126; Clark et al. (1989) J. Biol. Chem. 264:11544-11550; della- Cioppa et al. (1987) Plant Physiol. 84:965-968; Romer et al. (1993) Biochem. Biophys. Res Commun. 196: 1414-1421; and, Shah et al. (1986) Science 253:478-481.
  • the constructs may contain the nucleic acid sequence which encodes the entire HPO lyase protein, or a portion thereof.
  • the entire HPO lyase sequence is not required.
  • HPO lyase sequences used in constructs are intended for use as probes, it may be advantageous to prepare constructs containing only a particular portion of a HPO lyase encoding sequence, for example a sequence which is discovered to encode a highly conserved HPO lyase region.
  • Methods for the suppression of endogenous sequences in a host cell typically employ the transcription or transcription and translation of at least a portion of the sequence to be suppressed. Such sequences may be homologous to coding as well as non- coding regions of the endogenous sequence.
  • Transcript termination regions may be provided by the DNA sequence encoding the HPO lyase or a convenient transcription termination region derived from a different gene source, for example, the transcript termination region which is naturally associated with the transcript initiation region.
  • the transcript termination region which is naturally associated with the transcript initiation region.
  • constructs may be prepared to direct the expression of the HPO lyase sequences directly from the host plant cell plastid. Such constructs and methods are known in the art and are generally described, for example, in Svab, et al. (1990) Proc. Natl. Acad. Sci.
  • a plant cell, tissue, organ, or plant into which the recombinant DNA constructs containing the expression constructs have been introduced is considered transformed, transfected, or transgenic.
  • a transgenic or transformed cell or plant also includes progeny of the cell or plant and progeny produced from a breeding program employing such a transgenic plant as a parent in a cross and exhibiting an altered phenotype resulting from the presence of a HPO lyase nucleic acid sequence.
  • Plant expression or transcription constructs having an HPO lyase as the DNA sequence of interest for increased or decreased expression thereof may be employed with a wide variety of plant life, particularly, plant life involved in the production of vegetable oils for edible and industrial uses. Most especially preferred are seed, fruit, vegetable and leaf crops. Plants of interest include, but are not limited to, rapeseed (Canola and High Erucic
  • Acid varieties sunflower, safflower, cotton, soybean, peanut, coconut and oil palms, corn tomato, strawberry, bell pepper and melon.
  • this invention is applicable to dicotyledyons and monocotyledons species alike and will be readily applicable to new and/or improved transformation and regulation techniques.
  • HPO lyase constructs in plants to produce plants or plant parts, including, but not limited to leaves, stems, roots, reproductive, and seed, with a modified volatilecontent.
  • the gene sequences may be synthesized, either completely or in part, especially where it is desirable to provide plant-preferred sequences.
  • all or a portion of the desired structural gene may be synthesized using codons preferred by a selected host.
  • Host-preferred codons may be determined, for example, from the codons used most frequently in the proteins expressed in a desired host species.
  • antibody preparations, nucleic acid probes (DNA and RNA) and the like may be prepared and used to screen and recover "homologous" or "related" sequences from a variety of plant sources.
  • Homologous sequences are found when there is an identity of sequence, which may be determined upon comparison of sequence information, nucleic acid or amino acid, or through hybridization reactions between a known HPO LYASE and a candidate source. Conservative changes, such as Glu/Asp, Val/Ile, Ser/Thr, Arg/Lys and Gln/Asn may also be considered in determining sequence homology. Amino acid sequences are considered homologous by as little as 25% sequence identity between the two complete mature proteins. ⁇ See generally, Doolittle, R.F., OF URFS and ORFS (University Science Books, CA, 1986.) Thus, other HPO lyase may be obtained from the specific sequences provided herein.
  • Modified amino acid sequences include sequences which have been mutated, truncated, increased and the like, whether such sequences were partially or wholly synthesized. Sequences which are actually purified from plant preparations or are identical or encode identical proteins thereto, regardless of the method used to obtain the protein or sequence, are equally considered naturally derived.
  • antibodies to the protein can be prepared by injecting rabbits or mice with the purified protein or portion thereof, such methods of preparing antibodies being well known to those in the art. Either monoclonal or polyclonal antibodies can be produced, although typically polyclonal antibodies are more useful for gene isolation.
  • Western analysis may be conducted to determine that a related protein is present in a crude extract of the desired plant species, as determined by cross-reaction with the antibodies to the encoded proteins. When cross-reactivity is observed, genes encoding the related proteins are isolated by screening expression libraries representing the desired plant species.
  • Expression libraries can be constructed in a variety of commercially available vectors, including lambda gtl 1, as described in Sambrook, et al. ⁇ Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory, Cold Spring Harbor, New York).
  • Potential host cells include both prokaryotic and eukaryotic cells.
  • a host cell may be unicellular or found in a multicellar differentiated or undifferentiated organism depending upon the intended use.
  • Cells of this invention may be distinguished by having an HPO lyase foreign to the wild-type cell present therein, for example, by having a recombinant nucleic acid construct encoding a HPO lyase therein not native to the host species.
  • Preferred host cells include bacterial, yeast, insect, mammalian, and plant host cells. Particularly preferred host cells include yeast and plant host cells.
  • Prokaryotic cells include gram negative as well as gram positive bacteria, for example E. coli, and B. subtilis strains. Suitable examples are well known to the skilled artisan.
  • an HPO lyase isolated from cucumber hypocotyl is expressed in E coli, strain Ml 5.
  • the protein expressed from the E coli is capable of producing the aldehyde 3(Z)-nonenal and 2(E)-nonenal from linoleic acid 9-hydroperoxide.
  • the HPO lyase isolated from the cucumber hypocotyl encodes a 9-HPO lyase.
  • Eukaryotic host cells include fungi, including yeasts, insect cells, and plant cells.
  • the fungal recombinant vector may be any vector which can be conveniently subjected to recombinant DNA procedures.
  • the choice of a vector will typically depend on the compatibility of the vector with the fungal host cell into which the vector is to be introduced.
  • the vector may be a linear or a closed circular plasmid.
  • the vector system may be a single vector or plasmid or two or more vectors or plasmids which together contain the total DNA to be introduced into the genome of the fungal host.
  • the fungal vector may be an autonomously replicating vector, i.e., a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome.
  • the vector may contain any means for assuring self -replication.
  • the vector may be one which, when introduced into the fungal cell, is integrated into the genome and replicated together with the chromosome(s) into which it has been integrated.
  • the vector may rely on the nucleic acid sequence of the vector for stable integration of the vector into the genome by homologous or nonhomologous recombination.
  • the vector may contain additional nucleic acid sequences for directing integration by homologous recombination into the genome of the fungal host.
  • the additional nucleic acid sequences enable the vector to be integrated into the host cell genome at a precise location(s) in the chromosome(s).
  • there should be preferably two nucleic acid sequences which individually contain a sufficient number of nucleic acids, preferably 400bp to 1500bp, more preferably 800bp to lOOObp, which are highly homologous with the corresponding target sequence to enhance the probability of homologous recombination.
  • These nucleic acid sequences may be any sequence that is homologous with a target sequence in the genome of the fungal host cell and, furthermore, may be non-encoding or encoding sequences.
  • the vector may further comprise an origin of replication enabling the vector to replicate autonomously in the host cell in question.
  • origin of replications for use in a yeast host cell are the 2 micron origin of replication and the combination of CEN3 and ARS 1. Any origin of replication may be used which is compatible with the fungal host cell of choice.
  • the fungal vectors of the present invention preferably contain one or more selectable markers which permit easy selection of transformed cells.
  • a selectable marker is a gene the product of which provides, for example biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs and the like.
  • the selectable marker may be selected from the group including, but not limited to, amdS (acetamidase), argB (ornithine carbamoyltransferase), bar (phosphinothricin acetyltransf erase), hygB (hygromycin phosphotransf erase), niaD (nitrate reductase), pyrG (orotidine-5' -phosphate decarboxylase) and sC (sulfate adenyltransferase) and trpC (anthranilate synthase).
  • amdS acetamidase
  • argB ornithine carbamoyltransferase
  • bar phosphinothricin acetyltransf erase
  • hygB hygromycin phosphotransf erase
  • niaD nitrate reductase
  • pyrG orotidine-5' -phosphate decarboxy
  • a nucleic acid sequence of the present invention may be operably linked to a suitable promoter sequence.
  • the promoter sequence is a nucleic acid sequence which is recognized by the fungal host cell for expression of the nucleic acid sequence.
  • the promoter sequence contains transcription and translation control sequences which mediate the expression of the protein or fragment thereof.
  • a promoter may be any nucleic acid sequence which shows transcriptional activity in the fungal host cell of choice and may be obtained from genes encoding polypeptides either homologous or heterologous to the host cell.
  • suitable promoters for directing the transcription of a nucleic acid construct of the invention in a filamentous fungal host are promoters obtained from the genes encoding Aspergillus oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral alpha-amylase, Aspergillus niger acid stable alpha-amylase, Aspergillus niger or Aspergillus awamori glucoamylase (glaA), Rhizomucor miehei lipase, Aspergillus oryzae alkaline protease, Aspergillus oryzae triose phosphate isomerase, Aspergillus nidulans acetamidase and hybrid
  • a useful promoter is the Saccharomyces cerevisiae enolase (eno-1) promoter.
  • Particularly preferred promoters are the TAKA amylase, NA2-tpi (a hybrid of the promoters from the genes encoding Aspergillus niger neutral alpha -amylase and Aspergillus oryzae triose phosphate isomerase) and glaA promoters.
  • a protein or fragment thereof encoding nucleic acid molecule of the present invention may also be operably linked to a terminator sequence at its 3' terminus. The terminator sequence may be native to the nucleic acid sequence encoding the protein or fragment thereof or may be obtained from foreign sources.
  • any terminator which is functional in the fungal host cell of choice may be used in the present invention, but particularly preferred terminators are obtained from the genes encoding Aspergillus oryzae TAKA amylase, Aspergillus niger glucoamylase, Aspergillus nidulans anthranilate synthase, Aspergillus niger alpha- glucosidase and Saccharomyces cerevisiae enolase.
  • a protein or fragment thereof encoding nucleic acid molecule of the present invention may also be operably linked to a suitable leader sequence.
  • a leader sequence is a nontranslated region of a mRNA which is important for translation by the fungal host.
  • the leader sequence is operably linked to the 5' terminus of the nucleic acid sequence encoding the protein or fragment thereof.
  • the leader sequence may be native to the nucleic acid sequence encoding the protein or fragment thereof or may be obtained from foreign sources. Any leader sequence which is functional in the fungal host cell of choice may be used in the present invention, but particularly preferred leaders are obtained from the genes encoding Aspergillus oryzae TAKA amylase and Aspergillus oryzae triose phosphate isomerase.
  • a polyadenylation sequence may also be operably linked to the 3' terminus of the nucleic acid sequence of the present invention.
  • the polyadenylation sequence is a sequence which when transcribed is recognized by the fungal host to add polyadenosine residues to transcribed mRNA.
  • the polyadenylation sequence may be native to the nucleic acid sequence encoding the protein or fragment thereof or may be obtained from foreign sources.
  • polyadenylation sequence which is functional in the fungal host of choice may be used in the present invention, but particularly preferred polyadenylation sequences are obtained from the genes encoding Aspergillus oryzae TAKA amylase, Aspergillus niger glucoamylase, Aspergillus nidulans anthranilate synthase and Aspergillus niger alpha-glucosidase.
  • a protein or fragment thereof of the present invention may be linked to a signal peptide linked to the amino terminus of the protein or fragment thereof.
  • a signal peptide is an amino acid sequence which permits the secretion of the protein or fragment thereof from the fungal host into the culture medium.
  • the signal peptide may be native to the protein or fragment thereof of the invention or may be obtained from foreign sources.
  • the 5' end of the coding sequence of the nucleic acid sequence of the present invention may inherently contain a signal peptide coding region naturally linked in translation reading frame with the segment of the coding region which encodes the secreted protein or fragment thereof.
  • the 5' end of the coding sequence may contain a signal peptide coding region which is foreign to that portion of the coding sequence which encodes the secreted protein or fragment thereof.
  • the foreign signal peptide may be required where the coding sequence does not normally contain a signal peptide coding region.
  • the foreign signal peptide may simply replace the natural signal peptide to obtain enhanced secretion of the desired protein or fragment thereof.
  • the foreign signal peptide coding region may be obtained from a glucoamylase or an amylase gene from an Aspergillus species, a lipase or proteinase gene from Rhizomucor miehei, the gene for the alpha-factor from Saccharomyces cerevisiae, or the calf preprochymosin gene.
  • An effective signal peptide for fungal host cells is the Aspergillus oryzae TAKA amylase signal, Aspergillus niger neutral amylase signal, the Rhizomucor miehei aspartic proteinase signal, the Humicola lanuginosus cellulase signal, or the Rhizomucor miehei lipase signal.
  • any signal peptide capable of permitting secretion of the protein or fragment thereof in a fungal host of choice may be used in the present invention.
  • a protein or fragment thereof encoding nucleic acid molecule of the present invention may also be linked to a propeptide coding region.
  • a propeptide is an amino acid sequence found at the amino terminus of aproprotein or proenzyme. Cleavage of the propeptide from the proprotein yields a mature biochemically active protein. The resulting polypeptide is known as a propolypeptide or proenzyme (or a zymogen in some cases).
  • Propolypeptides are generally inactive and can be converted to mature active polypeptides by catalytic or autocatalytic cleavage of the propeptide from the propolypeptide or proenzyme.
  • the propeptide coding region may be native to the protein or fragment thereof or may be obtained from foreign sources.
  • the foreign propeptide coding region may be obtained from the Saccharomyces cerevisiae alpha- factor gene or Myceliophthora thermophila laccase gene (WO 95/33836, the entirety of which is herein incorporated by reference).
  • the procedures used to ligate the elements described above to construct the recombinant expression vector of the present invention are well known to one skilled in the art (see, for example, Sambrook et al, Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor, N.Y., (1989)).
  • the present invention also relates to recombinant fungal host cells produced by the methods of the present invention which are advantageously used with the recombinant vector of the present invention.
  • the cell is preferably transformed with a vector comprising a nucleic acid sequence of the invention followed by integration of the vector into the host chromosome.
  • the choice of fungal host cells will to a large extent depend upon the gene encoding the protein or fragment thereof and its source.
  • the fungal host cell may, for example, be a yeast cell or a filamentous fungal cell.
  • yeast as used herein includes Ascosporogenous yeast ⁇ Endomycetales), Basidiosporogenous yeast and yeast belonging to the Fungi Imperfecti ⁇ Blastomycetes).
  • the Ascosporogenous yeasts are divided into the families Spermophthoraceae and Saccharomycetaceae. The latter is comprised of four subfamilies, Schizosaccharomycoideae
  • Basidiosporogenous yeasts include the genera Leucosporidim, Rhodosporidium, Sporidiobolus, Filobasidium and Filobasidiella. Yeast belonging to the Fungi Imperfecti are divided into two families, Sporobolomycetaceae (for example, genera Sorobolomyces and Bullera) and Cryptococcaceae (for example, genus Candida).
  • yeast Since the classification of yeast may change in the future, for the purposes of this invention, yeast shall be defined as described in Biology and Activities of Yeast (Skinner et al, Soc. App. Bacteriol. Symposium Series No. 9, (1980), the entirety of which is herein incorporated by reference).
  • the biology of yeast and manipulation of yeast genetics are well known in the art ⁇ see, for example, Biochemistry and Genetics of Yeast, Bacil et al. (ed.), 2nd edition, 1987; The Yeasts, Rose and Harrison (eds.), 2nd ed., (1987); and The Molecular Biology of the Yeast Saccharomyces, Strathern et al. (eds.), (1981), all of which are herein incorporated by reference in their entirety).
  • the recombinant fungal host cells of the present invention may further comprise one or more sequences which encode one or more factors that are advantageous in the expression of the protein or fragment thereof, for example, an activator (e.g., a trans-acting factor), a chaperone and a processing protease.
  • an activator e.g., a trans-acting factor
  • a chaperone e.g., a processing protease.
  • the nucleic acids encoding one or more of these factors are preferably not operably linked to the nucleic acid encoding the protein or fragment thereof.
  • An activator is a protein which activates transcription of a nucleic acid sequence encoding a polypeptide (Kudla et al, EMBO 9:1355-1364(1990); Jarai and Buxton, Current Genetics 26:2238-244(1994); Verdier, Yeast 6:271-297(1990), all of which are herein incorporated by reference in their entirety).
  • the nucleic acid sequence encoding an activator may be obtained from the genes encoding Saccharomyces cerevisiae heme activator protein 1 (hapl), Saccharomyces cerevisiae galactose metabolizing protein 4 (gal4) and Aspergillus nidulans ammonia regulation protein (areA).
  • a chaperone is a protein which assists another protein in folding properly (Hard et al, TIBS 19:20-25 (1994); Bergeron et al, TIBS 19: 124-128 (1994); Demolder et al, J. Biotechnology 32: 179-189 (1994); Craig, Science 260:1902-1903(1993); Gething and Sambrook, Nature 355:33-45 (1992); Puig and Gilbert, J5r ⁇ /. Chem.
  • the nucleic acid sequence encoding a chaperone may be obtained from the genes encoding Aspergillus oryzae protein disulphide isomerase, Saccharomyces cerevisiae calnexin, Saccharomyces cerevisiae BiP/GRP78 and Saccharomyces cerevisiae Hsp70.
  • a processing protease is a protease that cleaves a propeptide to generate a mature biochemically active polypeptide (Enderlin and Ogrydziak, Yeast 10:61-19 (1994); Fuller et al, Proc. Natl. Acad. Sci. (U.S.A.) 86: 1434-1438 (1989); Julius et al, Cell 37: 1075-1089 (1984); Julius et al, Cell 32:839-852 (1983), all of which are incorporated by reference in their entirety).
  • the nucleic acid sequence encoding a processing protease may be obtained from the genes encoding Aspergillus niger Kex2, Saccharomyces cerevisiae dipeptidylaminopeptidase, Saccharomyces cerevisiae Kex2 and Yarrowia lipolytica dibasic processing endoprotease (xpr6). Any factor that is functional in the fungal host cell of choice may be used in the present invention.
  • Fungal cells may be transformed by a process involving protoplast formation, transformation of the protoplasts and regeneration of the cell wall in a manner known per se. Suitable procedures for transformation of Aspergillus host cells are described in EP 238 023 and Yelton et al, Proc. Natl. Acad. Sci. (U.S.A.) 81:1410- 414 (1984), both of which are herein incorporated by reference in their entirety. A suitable method of transforming
  • Fusarium species is described by Malardier et al, Gene 78.147-156 (1989), the entirety of which is herein incorporated by reference.
  • Yeast may be transformed using the procedures described by Becker and Guarente, In: Abelson and Simon, (eds.), Guide to Yeast Genetics and Molecular Biology, Methods Enzymol Volume 194, pp 182-187, Academic Press, Inc., New York; Ito et al, J. Bacteriology 153:163 (1983); Hinnen et al, Proc. Natl. Acad. Sci. (U.S.A.) 75:1920 (1978), all of which are herein incorporated by reference in their entirety.
  • the present invention also relates to methods of producing the protein or fragment thereof comprising culturing the recombinant fungal host cells under conditions conducive for expression of the protein or fragment thereof.
  • the fungal cells of the present invention are cultivated in a nutrient medium suitable for production of the protein or fragment thereof using methods known in the art.
  • the cell may be cultivated by shake flask cultivation, small-scale or large-scale fermentation (including continuous, batch, fed-batch, or solid state fermentations) in laboratory or industrial fermentors performed in a suitable medium and under conditions allowing the protein or fragment thereof to be expressed and/or isolated.
  • the cultivation takes place in a suitable nutrient medium comprising carbon and nitrogen sources and inorganic salts, using procedures known in the art ⁇ see, e.g., Bennett and LaSure (eds.), More Gene Manipulations in Fungi, Academic Press, CA, (1991), the entirety of which is herein incorporated by reference).
  • suitable media are available from commercial suppliers or may be prepared according to published compositions ⁇ e.g., in catalogues of the American Type Culture Collection, Manassas, VA). If the protein or fragment thereof is secreted into the nutrient medium, a protein or fragment thereof can be recovered directly from the medium. If the protein or fragment thereof is not secreted, it is recovered from cell lysates.
  • the expressed protein or fragment thereof may be detected using methods known in the art that are specific for the particular protein or fragment. These detection methods may include the use of specific antibodies, formation of an enzyme product, or disappearance of an enzyme substrate. For example, if the protein or fragment thereof has enzymatic activity, an enzyme assay may be used. Alternatively, if polyclonal or monoclonal antibodies specific to the protein or fragment thereof are available, immunoassays may be employed using the antibodies to the protein or fragment thereof. The techniques of enzyme assay and immunoassay are well known to those skilled in the art.
  • the resulting protein or fragment thereof may be recovered by methods known in the arts.
  • the protein or fragment thereof may be recovered from the nutrient medium by conventional procedures including, but not limited to, centrifugation, filtration, extraction, spray-drying, evaporation, or precipitation.
  • the recovered protein or fragment thereof may then be further purified by a variety of chromatographic procedures, e.g., ion exchange chromatography, gel filtration chromatography, affinity chromatography, or the like.
  • in vitro assays can be performed in insect cell cultures using baculovirus expression systems.
  • baculovirus expression systems are known in the art and are described by Lee, et al. U.S. Patent Number 5,348,886, the entirety of which is herein incorporated by reference.
  • expression constructs may be prepared to assay for protein activity utilizing different expression systems. Such expression constructs are transformed into yeast or prokaryotic host and assayed for HPO lyase activity. Such expression systems are known in the art and are readily available through commercial sources. The method of transformation in obtaining such transgenic plants is not critical to the instant invention, and various methods of plant transformation are currently available. Furthermore, as newer methods become available to transform crops, they may also be directly applied hereunder. For example, many plant species naturally susceptible to Agrobacterium infection may be successfully transformed via tripartite or binary vector methods of Agrobacterium mediated transformation. In many instances, it will be desirable to have the construct bordered on one or both sides by T-DNA, particularly having the left and right borders, more particularly the right border.
  • included with the DNA construct will be a structural gene having the necessary regulatory regions for expression in a host and providing for selection of transformant cells.
  • the gene may provide for resistance to a cytotoxic agent, e.g. antibiotic, heavy metal, toxin, etc., complementation providing prototrophy to an auxotrophic host, viral immunity or the like.
  • a cytotoxic agent e.g. antibiotic, heavy metal, toxin, etc.
  • complementation providing prototrophy to an auxotrophic host, viral immunity or the like.
  • one or more markers may be employed, where different conditions for selection are used for the different hosts.
  • Agrobacterium is used for plant cell transformation, a vector may be used which may be introduced into the Agrobacterium host for homologous recombination with T- DNA or the Ti- or Ri-plasmid present in the Agrobacterium host.
  • the Ti- or Ri-plasmid containing the T-DNA for recombination may be armed (capable of causing gall formation) or disarmed (incapable of causing gall formation), the latter being permissible, so long as the vir genes are present in the transformed Agrobacterium host.
  • the armed plasmid can give a mixture of normal plant cells and gall.
  • the expression or transcription construct bordered by the T-DNA border region(s) will be inserted into a broad host range vector capable of replication in E. coli and Agrobacterium, there being broad host range vectors described in the literature. Commonly used is pRK2 or derivatives thereof. See, for example, Ditta, et al, (Proc. Nat. Acad. Sci., U.S.A. (1980) 77:7347-7351) and EPA 0 120 515, which are incorporated herein by reference.
  • markers which allow for selection of transformed Agrobacterium and transformed plant cells.
  • a number of markers have been developed for use with plant cells, such as resistance to chloramphenicol, kanamycin, the aminoglycoside G418, hygromycin, or the like.
  • the particular marker employed is not essential to this invention, one or another marker being preferred depending on the particular host and the manner of construction.
  • explants For transformation of plant cells using Agrobacterium, explants may be combined and incubated with the transformed Agrobacterium for sufficient time for transformation, the bacteria killed, and the plant cells cultured in an appropriate selective medium. Once callus forms, shoot formation can be encouraged by employing the appropriate plant hormones in accordance with known methods and the shoots transferred to rooting medium for regeneration of plants. The plants may then be grown to seed and the seed used to establish repetitive generations and for isolation of vegetable oils.
  • methods for modifying the volatile composition of a host cell involve either increasing or decreasing the levels of volatile compounds in a host cell.
  • the method generally comprises the use of expression constructs to direct the expression of the polynucleotides of the present invention in a host cell.
  • the methods find use in modifying the levels of volatile compounds in plant parts including, but not limited to, leaves, roots, stems, flowers, tuber, fruits, legumes, seeds, and seed oils obtained from plant seeds.
  • expression constructs are provided which direct the expression of nucleic acid sequences encoding HPO lyase from Arabidopsis in bacterial and plant tissues.
  • the HPO lyase sequence of the present invention may be used in expression constructs to produce transgenic plants with improved green note flavor characteristics.
  • coexpression of a plant or other 9-HPO lyase and/or 13-HPO lyase in a plant tissue with a second gene involved in lipid peroxidation may also find use in the present invention.
  • coexpression of a 13-HPO lyase and/or 9-HPO lyase sequence in a plant tissue with a DNA sequence encoding for another protein involved in lipid peroxidation, such as a lipoxygenase may increase lipid peroxidation and increase the total short-chain aldehydes produced in the plant tissue.
  • Such an increase in short-chain aldehydes may increase the "green note" and/or "melon" flavor in an edible plant tissue.
  • Host cells expressing the 9-HPO lyases of the present invention provide a novel source of volatile aldehydes contributing to "green” and/or "melon” notes for use in various applications.
  • the host cells may also contain constructs providing for a increased production of enzymes involved in lipid peroxidation, for example lipoxygenase.
  • the host cells may also produce an increased amount of a particular fatty acid, or have a general increase in fatty acids.
  • Such host cells may be obtained using traditional breeding techniques, including mutagenesis, as well as hosts genetically engineered with such an altered fatty acid composition.
  • plant host cells containing a construct providing for the expression of the HPO lyase sequences of the present invention find use as a source for aldehydes in reactions for the production of alcohols for use in flavorings and aromatic products.
  • Such methods are known in the art and are described for example in U.S. Patent Number 5,695,973 and in PCT Publication WO 95/26413 the entireties of which are incorporated herein by reference.
  • a mixture of aldehydes and alcohols are obtained from such methods.
  • the methods generally involve a reaction mixture containing at least one unsaturated fatty acid, a plant material having a relatively high amount of enzyme activity of lipoxygenase and hydroperoxide lyase, and a source of alcohol dehydrogenase.
  • the unsaturated fatty acid may vary and include a single unsaturated fatty acid species as well as mixtures of several unsaturated fatty acids.
  • the fatty acids are provided in a free acid form, and examples include, but are not limited to oleic acid, linoleic acid, linolenic acid (alpha and gamma forms), arachidonic acid, eicosapentaenoic acid, and ricinoleic acid.
  • Sources of the alcohol dehydrogenase include yeasts, as well as non-yeast molds.
  • the alcohol dehydrogenase has the ability to convert an aldehyde to an alcohol.
  • the yeast and non-yeast molds further provide a source of nicotine adenine dinucleotide (N ADH) as a reducing agent.
  • N ADH nicotine adenine dinucleotide
  • the nucleic acid sequences of the present invention may also find use in expression constructs for the production of transgenic plants with increased resistance to various pathogens.
  • Transgenic plants expressing the HPO lyase sequence of the present invention may exhibit an enhanced hypersensitive-reaction (HR response) in response to pathogen attack due to the increased production of aldehydes involved in the HR response, such as (3Z)-hexenal and (2E)-hexenal (Croft, et al. (1993) Plant Physiol. 101:13-24).
  • aldehydes such as (2E)-hexenal
  • 2E-hexenal have also been shown to be effective anti-bacterial agents, further contributing to enhanced disease resistance (Croft, et al. (1993), supra).
  • these compounds may be involved in a general wounding response in plants.
  • 9-HPO lyase nucleic acid sequences in constructs to direct the expression of 9-HPO lyase in a prokaryotic and/or eukaryotic host cells for the production of flavorings and aromas.
  • a nucleic acid fragment encoding hydroperoxide lyase from Bell pepper has been previously cloned and sequenced (Matsui, et al. (1996) FEBS Letters 394:21-24).
  • the nucleotide sequence was used to search Genbank for HPO lyase related sequences.
  • Genbank One accession identified from Genbank (Accession Number Z97339,
  • RNA from seedling, inflorescence, and silique tissues of Arabidopsis thaliana is isolated for use in construction of complementary (cDNA) libraries.
  • the procedure is an adaptation of the DNA isolation protocol of Webb and Knapp (D.M. Webb and S.J. Knapp, (1990) Plant Molec. Reporter, 8, 180-185).
  • the following description assumes the use of lg fresh weight of tissue. Frozen seed tissue is powdered by grinding under liquid nitrogen.
  • the powder is added to 10ml REC buffer (50mM Tris-HCl, pH 9, 0.8M NaCl, lOmM EDTA, 0.5% w/v CTAB (cetyltrimethyl-ammonium bromide)) along with 0.2g insoluble polyvinylpolypyrrolidone, and ground at room temperature.
  • the homogenate is centrifuged for 5 minutes at 12,000 xg to pellet insoluble material.
  • the resulting supernatant fraction is extracted with chloroform, and the top phase is recovered.
  • the RNA is then precipitated by addition of 1 volume RecP (50mM Tris-HCL pH9, lOmM EDTA and 0.5% (w/v) CTAB) and collected by brief centrifugation as before.
  • RNA pellet is redissolved in 0.4 ml of 1M NaCl.
  • the RNA pellet is redissolved in water and extracted with phenol/chloroform.
  • Sufficient 3M potassium acetate (pH 5) is added to make the mixture 0.3M in acetate, followed by addition of two volumes of ethanol to precipitate the RNA. After washing with ethanol, this final RNA precipitate is dissolved in water and stored frozen.
  • total RNAs may be obtained using TRIzol reagent (BRL Life Technologies, Gaithersburg, MD) following the manufacturers protocol.
  • cDNA Complementary DNAs
  • a pair of primers were designed to amplify the 5' and 3' regions from the Arabidopsis HPO lyase-like cDNA from the libraries described in example 2 above. These two primers, HPOL28 (for 3' RACE, 5'-CGGTTCCTCTGCGCCTCTCTCGCCGGCG-3') and HPOL21 (for 5' RACE, 5'-GCGGAACCGGAGGACTAAAACGCAGC-3') are used in PCR reactions with Adapter specific primers (API 5'-CCATCCTAATACGACTCACTATAGGGC-3') provided in the Marathon cDNA Amplification Kit.
  • the primers API and HPOL 21 were used, and for the amplification of the 3' region the API primer was used in a reaction with the primer HPOL28.
  • the cycle conditions used are: 94°C for 1 minute followed by 5 rounds of 94°C for 5 seconds, 72°C for 4 minutes, followed by 5 rounds of amplification using 94°C for 5 seconds, 70°C for 4 minutes, and finally 25 cycles of 94°C for 5 seconds, and 68°C for 4 minutes.
  • a single fragment of 1100 bp was obtained from the 3 'RACE reaction with RNA obtained from the silique tissue described above.
  • ACTCACTATAGGGCTCGAGCGGC-3' to amplify an approximately 1000 bp fragment as a confirmation of the HPO lyase-like sequence.
  • the reamplified 1000 bp fragment was gel purified and cloned into the pCR2.1 TOPO vector (Invitrogen, Carlsbad, CA) to create the plasmid pCGN8094.
  • the 5' RACE reaction produced many non-specific fragments.
  • a 1000 bp fragment was excised from the gel and cloned into the pCR2.1 TOPO(Invitrogen) cloning vector to create the plasmid pCGN8091.
  • Figure 1 discloses the complete nucleotide sequence of the Arabidopsis HPO lyase.
  • the cDNA has a sequence of 1687 bp, and 47 and 137 bp of 5'- and 3'-noncoding regions, respectively. There is a stop codon in the 5'-noncoding region in-frame with the initiation codon.
  • the longest ORF encodes a polypeptide of 492 amino acids with a calculated molecular mass of 54851 Da.
  • Northern blot analysis of total RNA isolated from various organs, as well as wounded, methyl jasmonate, and pathogen challenged leaves, of Arabidopsis is performed.
  • RNA Total RNA is isolated from rosetta leaves, leaves on stems, stems, inflorescence, green buds, closed flowers, open flowers, siliques (5-10 mm), siliques ( ⁇ 5 mm), and 2, 3, 4, 5, and 6 day after germination seedlings using TRIzol reagent (Life Technologies, Gaithersburg, MD).
  • the isolated RNA samples (10-20 ⁇ g) are separated on a formaldehyde- agarose gel and transferred to Hybond-N (Amersham).
  • RNA is hybridized overnight with a probe corresponding to the 5' half of the Arabidopsis HPO lyase cDNA at 65°C in 6x SSC, 5x Denhardt's solution, 0.2% SDS, 20 ⁇ g/ml salmon sperm DNA, 20 mM sodium phosphate buffer, pH 7.0.
  • the hybridized membranes are washed once with 2x SSC, 0.1% SDS at 60°C for 20 minutes, and twice with 0.25x SSC, 0.1% SDS at 60° C for 20 minutes each.
  • a 1.6 kb transcript corresponding to the HPO lyase gene is observed in RNA isolated from all the tissue sources examined. The highest level of expression is observed in the inflorescence.
  • HPO lyase sequence is expressed in response to wounding and methyl jasmonate RNA is isolated from wounded leaves and leaves treated with methyl jasmonate (MJ). HPO lyase expression is also examined for induction by fungal attack.
  • Arabidopsis thaliana ecotype No-0 is grown in soil under 16 hour light at 22° C at 65% relative humidity for three weeks. For wounding, each leaf is wounded once with a hemostat on the upper third of the leaf in line with the midvein. In each rosette, half of the leaves are wounded and half are not. These are referred to as local and systemic leaves respectively.
  • MJ For treatment with MJ, plants are enclosed in airtight 9.25 L jars. Neat MJ (10 or 50 ⁇ l, Aldrich Co. Milwaukee, WI) is applied onto four cotton swabs and placed in the jars without directly touching the plants. Fresh MJ treated cotton swabs are replaced in the jar each time the jar is opened. For pathogen induction, spores of the fungus Botrytis cinerea are sprayed on the rosette leaves of 3 week old plants at a concentration of 10 6 spores per ml in 1% glucose. Total RNA is isolated from the tissues using TRIzol reagent (Life Technologies) as described by the manufacturer and transferred to membrane as described above.
  • TRIzol reagent Life Technologies
  • HPO lyase mRNA Expression of the HPO lyase mRNA is observed at 6 and 24 hours after wounding. High levels of HPO lyase induction are seen in leaves wounded with a hemostat. The induction is distinct after 6 hours of the treatment and the amount of HPO lyase mRNA increased at least until 24 hours. In the systemic leaves, induction of the HPO lyase mRNA is also evident. After 6 hours of treatment, the level of HPO lyase mRNA is almost the same as that of the local leaves, however, the amount increases only slightly afterwards and at 24 hours after treatment, the level is observably lower than that of the local leaves. Plants treated with methyl jasmonate demonstrated a low expression of HPO lyase are observed in both lO ⁇ l and 50 ⁇ l treatments at all time points examined.
  • a set of constructs are prepared for transformation into either plant or bacterial hosts to further characterize the Arabidopsis HPO lyase-like sequence.
  • the 5' RACE product in pCGN8091 was PCR amplified using the primers Alex2 (5'- CGGGATCC ATGTTGTTGAGAACGATGGCGGCG-3 ' ) and Alex4 (5 ' -
  • the Alex2 primer contains the restriction endonuclease site BamHI for the convenient cloning of the PCR product into the pQE30 expression vector (Qiagen, Hilden, Germany) in frame with the ATG start codon of the vector.
  • the PCR reaction mix contained 0.2 mM each of dATP, dCTP, dGTP and dTTP, 1.0% glycerol, 0.2 mM Tris-HCl
  • the resulting PCR product was digested with BamHI and Hindlll and ligated into the vector pQE30 to create the vector pCGN8099.
  • the 3' terminus of the Arabidopsis HPO lyase was cloned into the HindUI site of pCGN8099 from pCGN8094 to create the E. coli expression vector pCGN8100
  • a binary vector for plant transformation, pCGN5138, was constructed from pCGN1558 (McBride and Summerfelt, (1990) Plant Molecular Biology, 14:269-276).
  • the polylinker of pCGN1558 was replaced as an Hindlll/EcoRl fragment with a polylinker containing unique restriction endonuclease sites, Hindlll, SsellPstl, Notl, BamHI, Swal, Xbal, Pad, Ascl, and Aspl 18.
  • An antisense construct of the Arabidopsis HPO lyase-like nucleotide sequence was prepared for transformation of Arabidopsis.
  • the nucleic acid sequence encoding the 5' 1000 bp nucleotides from pCGN8091 were cloned as an EcoRI fragment into the plasmid pBluescript II SK (Stratagene, La Jolla, CA) to create the vector pCGN8093.
  • the 3' RACE product from pCGN8090 was cloned as a Hindlll fragment into pCGN8093 to create a full length HPO lyase coding sequence in the plasmid pCGN8094.
  • the Kpnl site of pCGN8094 was removed by digesting with Kpnl and filling in the site with Klenow fragment, and the HPO lyase coding sequence was cloned from this plasmid as a Smal fragment into the Stul site of pCGN8059. This yields the plasmid pCGN8101.
  • the plasmid pCGN8059 contains a multiple cloning site downstream of the 35S promoter and the hsp70 leader sequence to allow for the cloning of sequences for expression from the 35S promoter sequence.
  • This vector also contains the nopaline synthase transcription termination (nos 3') sequences (Fraley et al., Proc. Natl. Acad. Sci (1983) 80:4803-4807 and Depicker et al., J. Molec. Appl. Genet. (1982)
  • the expression vector pCGN8100 was transformed into E coli (strain M15, Qiagen, Hilden, Germany) using a calcium chloride procedure described inManiatis, et al. ((1989) Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York). Transformed colonies were screened by Western immunoblot analysis for expression of the HPO Lyase protein using antibodies raised to the bell pepper HPO lyase as described in Shibata, et al. (1995) Plant Cell Physiol. 97:1059- 1072. Hydroperoxide lyase activity was determined by gas chromotography (GC) methods described by Matsui, et al. (1991), Phytochemistry, 30:2109-2113.
  • GC gas chromotography
  • Example 6 Transformation of Arabidopsis with Antisense HPO Lyase Constructs A variety of methods have been developed to insert a DNA sequence of interest into the genome of a plant host to obtain the transcription or transcription and translation of the sequence to effect phenotypic changes.
  • the plant binary constructs pCGN8101 are used in plant transformation to direct the expression of the antisense nucleic acid sequence of the Arabidopsis HPO lyase-like sequence from plant tissues.
  • Transgenic Arabidopsis thaliana plants may be obtained by Agrobacterium-mediated transformation as described by Valverkens et ⁇ l, (Proc. Nat. Acad. Sci. (1988) 85:5536-
  • Transgenic Arabidopsis plants containing pCGN8101 are analyzed for the decreased production of Hexenal by High Pressure Liquied Chromotography (HPLC) analysis of protein extracts as described in Shibata et al. (1995) Plant Cell Physiol. 36: 147-156.
  • Transgenic plants overexpressing the Arabidopsis HPO lyase of the present invention may be screened using a photometric assay or by the HPLC assay which are both described in
  • Example 8 Identification of Additional HPO lyase Sequences Additional HPO lyase-like sequences are obtained from tomato and cucumber tissues. Total RNA was isolated from cucumber hypocotyls and tomato immature fruit tissue using TRIzol reagent (Gibco-BRL Life Technologies, Gaithersburg, MD) following the manufacturers protocol. Complementary DNAs (cDNA) are obtained using the Marathon cDNA Amplification
  • HPO lyase from bell pepper (Matsui, et al. (1996) supra), banana (European Patent Application, Publication Number EP 0 801 133 A2) and Arabidopsis were aligned using ClustalW (http://www.clustalw.genome.ad.jp/) and seven conserved peptide sequences were identified (see Figure 7 for positions, Table 2 for a listing).
  • a set of synthetic oligonucleotides (Table 2) are synthesized for use in polymerase chain reactions with the cDNAs obtained above to identify sequences which are homologous to HPO lyase sequences.
  • the PCR reactions are carried out using Advantage cDNA
  • the letter “S” in the oligonucleotide name designates a PCR primer designed to amplify the sense strand, or forward reaction primer.
  • the letters “AS” designates a PCR primer designed to amplify the antisense strand, or reverse reaction primer.
  • the letters “N” represents an A, C, G, or a T
  • the letter “S” represents a C or a G in that position
  • the letter “Y” represents a C or a T
  • the letter “R” represents an A or a G in that position.
  • the 475 bp PCR product from tomato and cucumber were cloned into the plasmid pCR2.1TOPO (invitrogen) to yield the plasmids T15 and C15 respectively.
  • PCR reactions with 6HPOL4S and 11HPOL7AS a single product, of approximately 200 bp, was obtained from amplification reactions with cDNA obtained from cucumber hypocotyl tissue.
  • the 200 bp product was cloned into pCR2.1 TOPO (Invitrogen), to create the plasmid C17.
  • the nucleotide sequence of each PCR product was determined by automated sequencing. The sequences obtained are compared to nucleic acid and amino acid sequences of HPO lyase sequences from bell pepper, Arabidopsis, and banana leaf, as well as to DNA and amino acid sequences coding for allene oxide synthases from guayule ((1995) J. Biol. Chem. 270(15):8487-8494), flaxseed ((1993) Proc Natl Acad Sci USA 90(18):8519-8523) and Arabidopsis.
  • the C17 sequence also follows a similar pattern of similarity to the HPO lyase sequences. Thus, the T15 and C17 sequences encode proteins highly similar to HPO lyase.
  • the results of the sequence comparisons demonstrate that the C15 nucleic acid sequence is between 50% and 54% similar to the other HPO lyase nucleic acid sequences and about 58% similar to the allene oxide synthase DNA sequences. Furthermore, the deduced amino acid sequence of C15 is between about 38% and 42% similar to the HPO lyase amino acid sequences and about 51% similar to the AOS amino acid sequences. Thus, the C 15 sequence encodes a protein which is divergent from both the known HPO lyase sequences, and is more similar to allene oxide synthase sequences.
  • the nucleotide sequence of each PCR product was determined by automated sequencing. The sequences obtained are used to search Genbank. Search results identify the sequences from T15 and C17 as being similar to HPO lyase sequences, while the sequence of C15 is similar to allene oxide synthase sequences.
  • RACE PCR reactions are employed using the Marathon cDNA Amplification kit (Clontech) according to the manufacturers protocol, and the oligonucleotides shown in Table 3.
  • KMC 10-1 5' -CGGTGGAGATCCTCGCC ACCGGTGCCGACCC-3 ' 2KMC 10-2: 5' -CTTCCTTCACGGTTGTCCTCACTTCCTCCGCC AG-3 ' 3KMC17-1: 5'-TCCAGCAGCGCTGCCCCTTTCTCTCCCCGG-3' 4KMC17-2: 5'-CACTGTTTGTTCTTCTCGCTCGGTGTCCCCG-3' 5KMC 10-3: 5' -GGGTCGGC ACCGGTGGCGAGGATCTCC ACCG-3 ' 6KMC10-4: 5'-CTGGCGGAGGAAGTGAGGACAACCGTGAAGGAAG-3' 7KMC 17-3: 5' -CCGGGGAGAAAGGGGCAGCGCTGCTGG-3 ' 8KMC17-4: 5'-CGGGGACACCGAGCGAGAAGAACAAACAGTG-3'
  • 9KMT15-1 5'-GACTTGGTACTGGTGGACTAAGCCTAAGTGTTTC-3'
  • 10KMT15-2 5'-GGCTGATAACCACAAAGAAGCTCCCCTTTC-3'
  • 11KMT15-3 5'-GAAACACTTAGGCTTAGTCCACCAGTACCAAGTC-3'
  • 12KMT 15-4 5' -GAAAGGGGAGCTTCTTTGTGGTTATCAGCC-3 '
  • PCR products from the amplification reactions with DNA obtained from tomato and cucumber are cloned into pCR2.1 TOPO.
  • the sequences of the 5' and 3 '-RACE products from tomato (pCGN8303 (5' RACE) and pCGN8304 (3' RACE)), cucumber, C15 (pCGN8302 (5'RACE) and pCGN8306 (3' RACE)) and C17 (pCGN8301 (5' RACE) and pCGN8307 (3' RACE)) are sequenced and aligned with the respective sequences obtained from pCGN8305, pCGN8309, and pCGN8308 to obtain preliminary full length sequences corresponding to a tomato HPO lyase-like sequence (Figure 4), a cucumber HPO lyase-like sequence ( Figure 6) and a cucumber allene oxide synthase-like sequence ( Figure 5).
  • a set of constructs are prepared for transformation into either plant or bacterial hosts to further characterize the novel sequence from cucumber.
  • the sequences from the 5' RACE (pCGN8302) and 3' RACE (pCGN8306) were PCR amplified and combined at a unique restriction endonuclease site.
  • the 5' C15 sequence is amplified using primers (4KMC15ES1 5'- CGGGATCCATGGCTTCTTCCTCCCCTGAACTTC-3' and 5KMC15EAS2 5'- TGCCGACCCATTTC AGT ATAGTGGG-3 ' ) in PCR amplification reactions described above.
  • the primer 4KMC15EAS1 amplifies from the 5' region and contains the start codon (ATG), and a BamHI site.
  • the 3' C15 sequence is amplified using the API primer provided in the Marathon Kit (BRL-Lifetechnologies, Gaithersburg, MD) and the primer 6KMC15ES3 (5'- TTCACACCATTCCCCTGCCTTTCTTCCC-3').
  • the sequence of the C15 full length clone is shown in Figure 6.
  • the 5' RACE PCR amplification product is digested with BamHI andXbal (unique site endogenous to the C 15 sequence) and cloned into the expression vector pQE30 (Invitrogen) with the amplification product of the 3' RACE PCR reaction digested withXb l and Smal.
  • This construct provides a full length encoding sequence of the C15 cDNA in the E. coli expression vector to create the vector pCGN8333.
  • the full length sequence is also cloned into the plasmid pUCl 19 to create the vector pCGN8334.
  • a binary vector for plant transformation was constructed from pCGN1558 (McBride and Summerfelt, (1990) Plant Molecular Biology, 14:269-276).
  • the polylinker of pCGN1558 was replaced as an Hindl ⁇ I/EcoRI fragment with a polylinker containing unique restriction endonuclease sites, Hindlll, Ssel/Pstl, Notl, BamHI, Swal, Xbal, Pad, Ascl, and Aspl 18.
  • the full length coding sequence of C15 is cloned to be expressed from the plant constitutive promoter 35S for expression in plants.
  • the expression cassette is cloned into the binary vector pCGN5138 to create the vector ⁇ CGN8337.
  • the expression vector pCGN8333 was transformed into E coli (strain M15, Qiagen, Hilden, Germany) using a calcium chloride procedure described in Maniatis, et al. ((1989)
  • Hydroperoxide lyase activity was determined by spectrophotometric and gas chromotography (GC) methods described by Matsui, et al. (1991), Phytochemistry, 30:2109- 2113, using both linolenic acid 13-hydroperoxide and linolenic acid 9-hydroperoxide as substrates.
  • GC gas chromotography
  • the results of the gas chromotography assay demonstrate that the protein encoded by the cucumber C15 sequence has greater activity toward linolenic acid 9- hydroperoxide (Figure 9B) substrates than linolenic acid 13-hydroperoxide substrates ( Figure 9A).
  • the results of the spectrophotometric assays further demonstrate the preference of the protein encoded by cucumber HPO lyase nucleic acid sequence for 9-Hydroperoxide substrates.
  • the results of the spectrophotometric assay are presented in Figure 10.
  • the cucumber C15 sequence represents the first known cloning of a nucleic acid sequence encoding a 9-hydroperoxide lyase.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention concerne une hydroperoxyde lyase de plante et des polynucléotides ou des polypeptides de HPO lyase ; des produits de recombinaison d'ADN utiles pour l'expression d'une HPO lyase de plante dans une cellule ; des produits de recombinaison d'ADN utiles pour l'expression antisens d'une HPO lyase de plante dans une cellule de plante. Ces produits de recombinaison contiendront une séquence d'ADN codant la HPO lyase de plante sous le contrôle d'éléments régulateurs capables de diriger de façon préférentielle l'expression de cette HPO lyase dans le tissu de la plante, quand ce produit de recombinaison est exprimé dans une plante transgénique. Elle concerne également des procédés de mise en application d'une séquence d'ADN codant une HPO lyase de plante afin de modifier les aldéhydes volatils dans le tissu de la plante, ainsi que des procédés servant à augmenter la résistance d'une plante à des maladies.
EP99930829A 1998-06-26 1999-06-25 Sequences d'acides nucleiques d'hydroperoxyde lyase d'acides gras Withdrawn EP1032694A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9092498P 1998-06-26 1998-06-26
US90924P 1998-06-26
US12196599P 1999-02-26 1999-02-26
US121965P 1999-02-26
PCT/US1999/014777 WO2000000627A2 (fr) 1998-06-26 1999-06-25 Sequences d'acides nucleiques d'hydroperoxyde lyase d'acides gras

Publications (1)

Publication Number Publication Date
EP1032694A2 true EP1032694A2 (fr) 2000-09-06

Family

ID=26782789

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99930829A Withdrawn EP1032694A2 (fr) 1998-06-26 1999-06-25 Sequences d'acides nucleiques d'hydroperoxyde lyase d'acides gras

Country Status (5)

Country Link
EP (1) EP1032694A2 (fr)
KR (1) KR20010023362A (fr)
CN (1) CN1321196A (fr)
CA (1) CA2301856A1 (fr)
WO (1) WO2000000627A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592619B2 (en) 1996-01-02 2003-07-15 University Of Cincinnati Heart wall actuation device for the natural heart
US6200794B1 (en) 1998-05-13 2001-03-13 Fimenrich Sa Guava (Psidium guajava) 13-hydroperoxide lyase and uses thereof
WO2000022145A2 (fr) * 1998-10-13 2000-04-20 Pioneer Hi-Bred International, Inc. Gene d'hydroperoxyde-lyase tire du mais et procedes d'utilisation
WO2000050575A2 (fr) * 1999-02-26 2000-08-31 Calgene Llc Sequences d'acides nucleiques de 9-hydroperoxyde lyase d'acides gras
US6271018B1 (en) * 2000-03-29 2001-08-07 Vanderbilt University Muskmelon (Cucumis melo) hydroperoxide lyase and uses thereof
US6780621B2 (en) 2000-05-24 2004-08-24 Firmenich Sa Guava (Psidium guajava) 13-hydroperoxide lyase and uses thereof
DE10028639C2 (de) * 2000-06-09 2003-11-06 Ipk Inst Fuer Pflanzengenetik Verfahren zur Herstellung von C9-Aldehyden, C9-Alkoholen sowie deren Ester
AU2002223038A1 (en) * 2000-11-06 2002-05-15 Centre National De La Recherche Scientifique Nucleic acids and polypeptides specifically expressed in cells of the transfer zone of a plant seed and uses thereof
AU2002215773B2 (en) 2000-12-18 2007-06-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Hydroperoxide lyase regulatory region

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844121A (en) * 1996-01-19 1998-12-01 The Texas A & M University System Method of inhibiting mycotoxin production in seed crops by modifying lipoxygenase pathway genes
EP0801133B1 (fr) * 1996-04-15 2004-09-08 Givaudan SA Lyases de hydroxy-peroxyde

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0000627A2 *

Also Published As

Publication number Publication date
KR20010023362A (ko) 2001-03-26
WO2000000627A2 (fr) 2000-01-06
CA2301856A1 (fr) 2000-01-06
CN1321196A (zh) 2001-11-07
WO2000000627A3 (fr) 2000-07-06

Similar Documents

Publication Publication Date Title
JP4481819B2 (ja) ジアシルグリセロールアシルトランスフェラーゼ核酸配列および関連生成物
US7148336B2 (en) Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acid levels
CN107858204B (zh) 产生ω-3脂肪酸的酶和方法
US7473820B2 (en) Flax (Linum usitatissimum L.) seed-specific promoters
EP0977866B1 (fr) Enzymes de modification d'acides gras provenant de graines en cours de developpement de vernonia galamenensis
JP2006509494A (ja) 真菌からの脂肪酸不飽和化酵素
JPH08510381A (ja) 植物成長の調節
US7732678B1 (en) Cotton fiber transcriptional factors
TW201634695A (zh) 降低植物種子中飽和脂肪酸含量之技術（三）
JP2017537633A (ja) 低飽和脂肪酸または無飽和脂肪酸トランスジェニックキャノーラの生成
AU2013340445A1 (en) Improved acyltransferase polynucleotides, polypeptides, and methods of use
AU2013340444B2 (en) Novel acyltransferase polynucleotides, polypeptides, and methods of use
EP1032694A2 (fr) Sequences d'acides nucleiques d'hydroperoxyde lyase d'acides gras
WO2000050575A2 (fr) Sequences d'acides nucleiques de 9-hydroperoxyde lyase d'acides gras
WO2011010485A1 (fr) Procédé de production d'un éicosanoïde, gène de biosynthèse d'un éicosanoïde dérivé d'une marchantie polymorphe, et utilisation du gène
US8053633B1 (en) Fungal desaturases and related methods
MXPA00002004A (en) Fatty acid hydroperoxide lyase nucleic acid sequences
EP1705249A1 (fr) Procédé de production de plantes à biomasse accrue
EP1925671A1 (fr) Promoteurs spécifiques à la graine lin (Linum usitatissimum L.)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000323

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030103

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1030434

Country of ref document: HK